Search for Clinical Trial Results

Sponsored By

Anaplastic Oligoastrocytoma - 21 Studies Found

Status Study
Active, not recruiting Study Name: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
Condition:
  • Anaplastic Astrocytoma
  • Anaplastic Oligodendroglioma
  • Date: 2012-07-04
    Interventions:
    • Drug: Carmustine(BCNU) Carmust
Active, not recruiting Study Name: Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
Condition:
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Anaplastic
    Date: 2013-11-08
    Interventions: Biological: Toca 511 All subjects will receive Toca 511, a retroviral replicating vector that expresses
Active, not recruiting Study Name: Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Condition:
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Anaplastic
    Date: 2011-11-04
    Interventions: Biological: Toca 511 All subjects will receive Toca 511, a retroviral replicating vector that expresses
Completed Study Name: Sorafenib in Newly Diagnosed High Grade Glioma
Condition:
  • Glioblastoma
  • Gliosarcoma
  • Anaplastic Astrocytoma
  • Date: 2009-04-17
    Interventions: Drug: Sorafenib dose escalation Sorafenib dose escalation scheme: 3 first patients: 200 mg/d, if dose li
Terminated Study Name: Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
Condition:
  • Anaplastic Astrocytoma
  • Anaplastic Oligodendroglioma
  • Date: 2014-05-29
    Interventions:
    • Dietary Supplement: ascorbic acid

Completed Study Name: BIBF 1120 for Recurrent High-Grade Gliomas
Condition:
  • Glioblastoma
  • Gliosarcoma
  • Anaplastic Astrocytoma
  • Date: 2011-06-21
    Interventions: Drug: BIBF 1120 200 mg BID oral for 28 day cycle
Terminated Study Name: Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols
Condition:
  • Glioblatoma
  • Gliosarcoma
  • Anaplastic Astrocytoma
  • Date: 2002-05-02
Recruiting Study Name: WEE1 Inhibitor AZD1775 and Local Radiation Therapy in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
Condition:
  • Diffuse Intrinsic Pontine Glioma
  • Untreated Childhood Anaplastic Astrocytoma
  • Other: Laboratory Biomarker Analysis

Terminated Study Name: Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
Condition:
  • High Grade Glioma: Glioblastoma (GBM)
  • High Grade Glioma: Gliosarcoma
  • Drug: Plerixafor Given subcuta
Not yet recruiting Study Name: Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
Condition:
  • Malignant Glioma
  • Anaplastic Astrocytoma